Medical Devices: Page 45
-
Stryker raises earnings forecast as procedures return to pre-pandemic levels
The company expects elevated procedure demand to continue into 2024 due to surgery backlogs.
By Elise Reuter • Aug. 4, 2023 -
Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery
The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.
By Susan Kelly • Aug. 4, 2023 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Penumbra says stroke device delayed at least 12 months due to FDA request
The setback stalls “a meaningful new product catalyst,” but the growth of Penumbra’s other devices could cushion the impact, analysts said.
By Nick Paul Taylor • Aug. 4, 2023 -
Outset pauses shipments of dialysis accessory after FDA warning letter, denting sales outlook
The halt prompted the company to predict it will now hit the bottom end of its full-year revenue range, a revision that surprised some analysts.
By Nick Paul Taylor • Aug. 4, 2023 -
BD prepares for relaunch of Alaris pump, raises revenue forecast
The pump relaunch isn’t expected to contribute much to this year’s revenue, but could help Becton Dickinson reach its long-term financial goals.
By Elise Reuter • Aug. 3, 2023 -
CMS inpatient final rule will have muted impact on medtech companies, analysts say
The CMS disclosed add-on payments that will continue in 2024 and named products that received approval under the breakthrough devices pathway.
By Nick Paul Taylor • Aug. 3, 2023 -
Baxter recalls infusion pumps over risk of false alarms
Baxter made a software fix last year after it found pumps weren't issuing an occlusion alarm. Now, the devices might issue alarms even when there isn't a blockage.
By Elise Reuter • Aug. 2, 2023 -
Cooper scraps $875M takeover of Cook Medical business after FTC investigation
The FTC said ending the planned acquisition “ensures that critical reproductive health markets remain competitive.”
By Nick Paul Taylor • Aug. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Varian logistics slow growth at Siemens Healthineers in Q3
Healthineers has worked through some logistics problems but now faces a race to install Varian equipment at customer sites.
By Nick Paul Taylor • Aug. 2, 2023 -
Terumo receives FDA clearance for automated whole blood processing system
The device automates additional steps needed to separate platelets from the rest of the blood, giving blood centers more capacity.
By Elise Reuter • Aug. 1, 2023 -
Abbott pulls Trifecta heart valves from US market over deterioration rate
The action removes a rival to Edwards Lifesciences and Medtronic for the surgical aortic valve replacement market.
By Nick Paul Taylor • Aug. 1, 2023 -
Vicarious expects to perform first human procedure with robot next year
The company, after disclosing layoffs in February, said it has gained clarity on its regulatory pathway following pre-submission meetings with the FDA.
By Susan Kelly • July 31, 2023 -
Integra warns impact of plant closure will continue into 2024, with delays possible
Management has built a buffer into the plan but cautioned unforeseen events could cause its timeline to slip.
By Nick Paul Taylor • July 31, 2023 -
GE HealthCare oxygen sensor recall gets Class I label from FDA
GE warned that the sensors can limit the effectiveness of cardiac defibrillation, expose patients to electrical currents, or give inaccurate blood oxygen readings.
By Nick Paul Taylor • July 31, 2023 -
Thermo Fisher eyes $450M in cost cuts due to slowing demand
The pullback in spending will include layoffs and lower investments in some areas of the business, company executives said.
By Susan Kelly • July 28, 2023 -
FDA shares draft guidance on studying medtech treatments for opioid use disorder
The FDA aims to address challenges including inaccurate self-reported drug use, missing data and the need to show the durability of the treatment.
By Nick Paul Taylor • July 28, 2023 -
Dexcom hails CGM share gains as driver of 25% revenue growth in Q2
International market share gains and expanding coverage in the U.S. led the CGM maker to raise its revenue forecast for 2023.
By Nick Paul Taylor • July 28, 2023 -
Abbott recall of heart catheter categorized as Class I event
Abbott plans to win approval for a modified steerable product and bring it to market as a replacement for the recalled device.
By Nick Paul Taylor • July 27, 2023 -
Boston Scientific raises full-year forecast again, fueled by strong Q2
The company boosted its outlook for the second consecutive quarter and said patients face waitlists for procedures using its devices.
By Susan Kelly • July 27, 2023 -
Edwards’ TAVR results hurt by pandemic aftereffects and competition in Q2
Staffing is still not where Edwards “would have projected to be in absence of the pandemic.”
By Nick Paul Taylor • July 27, 2023 -
Teleflex to expand urology portfolio with $600M acquisition
The company reached an agreement to buy Palette Life Sciences, as it looks to grow through acquisitions.
By Elise Reuter • July 26, 2023 -
Regulatory specialist pleads guilty to forging FDA clearance letters
The former employee of B. Braun’s Aesculap division admitted creating the letters on FDA letterhead and forging an agency official’s digital signature.
By Susan Kelly • July 26, 2023 -
FDA adopts new sterilization standard to support switch from ethylene oxide
The regulator said it added the alternative sterilization method to its database in response to pressure to reduce EtO use and to support supply chain resiliency.
By Nick Paul Taylor • July 26, 2023 -
GE HealthCare plans cost cuts, raises earnings forecast
The company plans to improve its margins by cutting down on service agreements and by driving more efficiency in manufacturing and supply chain.
By Elise Reuter • July 25, 2023 -
Inspire Medical hires Medtronic veteran as new strategy chief
Carlton Weatherby has been tapped to help the sleep apnea implant maker scale up its business.
By Susan Kelly • July 24, 2023